FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015261503> ?p ?o ?g. }

• W2015261503 endingPage "848" @default.
• W2015261503 startingPage "839" @default.
• W2015261503 abstract "Chronic hepatitis B infection continues to be a major public health concern worldwide. The natural history of the disease can be divided into 4 different phases: immune tolerance, immune clearance, inactive carrier, and reactivation. The goals of treatment are sustained viral suppression, normalization of ALT, and improvement in liver histology. Antiviral agents in current use include standard interferon-alpha, lamivudine, and adefovir. With an improved understanding of the natural history of the disease and a growing repertoire of antiviral drugs, the important questions are: who should receive treatment, what is the best agent to use, and what is the optimal duration of therapy? Treatment is indicated for patients in the immune clearance and reactivation phases. Patients with high pretreatment ALT level, detectable HBV DNA in the serum, and active inflammation on liver biopsy are predicted to have the highest chance of response to treatment. The choice of a particular agent must balance long-term benefits such as the likelihood of a sustained response against long-term risks such as drug resistance. Interferon treatment leads to a more durable response but is associated with unpleasant side effects. Lamivudine is effective and well tolerated but requires long-term therapy and is associated with drug resistance. Adefovir has proven efficacy and a very low rate of drug resistance but is associated with a small risk of reversible nephrotoxicity. For HBeAG-positive chronic hepatitis B and HBeAG-negative chronic hepatitis B, the duration of interferon therapy is 4-6 months and 12 months, respectively. Duration of treatment is at least 1 year with lamivudine and adefovir; longer duration of treatment is needed in most patients, but the optimal duration of treatment and the criteria for stopping treatment have not been established." @default.
• W2015261503 created "2016-06-24" @default.
• W2015261503 creator A5065724405 @default.
• W2015261503 creator A5077140895 @default.
• W2015261503 date "2004-10-01" @default.
• W2015261503 modified "2023-10-17" @default.
• W2015261503 title "Treatment of chronic hepatitis B: Who to treat, what to use, and for how long?" @default.
• W2015261503 cites W1647175450 @default.
• W2015261503 cites W1725758063 @default.
• W2015261503 cites W1966093728 @default.
• W2015261503 cites W1970657877 @default.
• W2015261503 cites W1980874631 @default.
• W2015261503 cites W1996800586 @default.
• W2015261503 cites W2002548940 @default.
• W2015261503 cites W2005513292 @default.
• W2015261503 cites W2006698257 @default.
• W2015261503 cites W2009944703 @default.
• W2015261503 cites W2010318719 @default.
• W2015261503 cites W2011997149 @default.
• W2015261503 cites W2012090731 @default.
• W2015261503 cites W2025132168 @default.
• W2015261503 cites W2027545702 @default.
• W2015261503 cites W2038358235 @default.
• W2015261503 cites W2039294886 @default.
• W2015261503 cites W2041932387 @default.
• W2015261503 cites W2052968140 @default.
• W2015261503 cites W2053396830 @default.
• W2015261503 cites W2071167068 @default.
• W2015261503 cites W2084713036 @default.
• W2015261503 cites W2084720260 @default.
• W2015261503 cites W2093604720 @default.
• W2015261503 cites W2097754581 @default.
• W2015261503 cites W2102261325 @default.
• W2015261503 cites W2112145547 @default.
• W2015261503 cites W2112150016 @default.
• W2015261503 cites W2120128540 @default.
• W2015261503 cites W2127685726 @default.
• W2015261503 cites W2142338711 @default.
• W2015261503 cites W2149337924 @default.
• W2015261503 cites W2149836081 @default.
• W2015261503 cites W2150966027 @default.
• W2015261503 cites W2155687271 @default.
• W2015261503 cites W2156015715 @default.
• W2015261503 cites W2161280033 @default.
• W2015261503 cites W2166826446 @default.
• W2015261503 cites W2169342982 @default.
• W2015261503 cites W2170268409 @default.
• W2015261503 cites W2231141014 @default.
• W2015261503 cites W2293495463 @default.
• W2015261503 cites W2338794667 @default.
• W2015261503 cites W2393327590 @default.
• W2015261503 cites W2146003334 @default.
• W2015261503 cites W3145719428 @default.
• W2015261503 doi "https://doi.org/10.1016/s1542-3565(04)00386-6" @default.
• W2015261503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15476146" @default.
• W2015261503 hasPublicationYear "2004" @default.
• W2015261503 type Work @default.
• W2015261503 sameAs 2015261503 @default.
• W2015261503 citedByCount "26" @default.
• W2015261503 countsByYear W20152615032012 @default.
• W2015261503 countsByYear W20152615032013 @default.
• W2015261503 countsByYear W20152615032014 @default.
• W2015261503 countsByYear W20152615032015 @default.
• W2015261503 countsByYear W20152615032018 @default.
• W2015261503 countsByYear W20152615032022 @default.
• W2015261503 crossrefType "journal-article" @default.
• W2015261503 hasAuthorship W2015261503A5065724405 @default.
• W2015261503 hasAuthorship W2015261503A5077140895 @default.
• W2015261503 hasConcept C114851261 @default.
• W2015261503 hasConcept C126322002 @default.
• W2015261503 hasConcept C142462285 @default.
• W2015261503 hasConcept C203014093 @default.
• W2015261503 hasConcept C2522874641 @default.
• W2015261503 hasConcept C2775934546 @default.
• W2015261503 hasConcept C2775940106 @default.
• W2015261503 hasConcept C2776461080 @default.
• W2015261503 hasConcept C2777382497 @default.
• W2015261503 hasConcept C2777410769 @default.
• W2015261503 hasConcept C2777766500 @default.
• W2015261503 hasConcept C2777869810 @default.
• W2015261503 hasConcept C2779517838 @default.
• W2015261503 hasConcept C2780040827 @default.
• W2015261503 hasConcept C2780593183 @default.
• W2015261503 hasConcept C3020491458 @default.
• W2015261503 hasConcept C71924100 @default.
• W2015261503 hasConcept C86803240 @default.
• W2015261503 hasConcept C89423630 @default.
• W2015261503 hasConcept C90924648 @default.
• W2015261503 hasConceptScore W2015261503C114851261 @default.
• W2015261503 hasConceptScore W2015261503C126322002 @default.
• W2015261503 hasConceptScore W2015261503C142462285 @default.
• W2015261503 hasConceptScore W2015261503C203014093 @default.
• W2015261503 hasConceptScore W2015261503C2522874641 @default.
• W2015261503 hasConceptScore W2015261503C2775934546 @default.
• W2015261503 hasConceptScore W2015261503C2775940106 @default.
• W2015261503 hasConceptScore W2015261503C2776461080 @default.
• W2015261503 hasConceptScore W2015261503C2777382497 @default.
• W2015261503 hasConceptScore W2015261503C2777410769 @default.

• next